Context Therapeutics amended charter to authorize 310 million shares
Context Therapeutics amended its charter to authorize 310 million shares. The increase supports potential future financing needs.
View filing at SEC.gov →1 most recent filing and news item mentioning CNTX. Updated every 60 seconds.
curl "https://api.brieftape.com/v1/tickers/CNTX/news?limit=20"
Pull CNTX filings straight into your trading bot, model, or app.
Get an API key — free tier: 10,000 calls/dayContext Therapeutics amended its charter to authorize 310 million shares. The increase supports potential future financing needs.
View filing at SEC.gov →